Delhi High Court extends the deadline to submit comments on Delhi High Court Intellectual Property Rights Division Rules, 2021

/ By / Others

The Delhi High Court Registry on October 26, 2021 announced an extension for submitting suggestions and comments on the proposed Delhi High Court Intellectual Property Rights Division Rules, 2021. As per this, the new deadline stands as November 10, 2021.  The proposed rules come out as a result of the Tribunal Reforms Act, 2021, and the recommendations made by the committee constituted by the Chief Justice of the Delhi High Court Justice D. N Patel, to further the implementation of […]

Delhi High Court extends the deadline to submit comments on Delhi High Court Intellectual Property Rights Division Rules, 2021 Read More »

Drug Price Controls in the US: Same, Same but Different?

/ By / Drug Regulation, Innovation

In 2017, when India introduced price controls on coronary stents, the United States Trade Representative (USTR) had requested the Prime Minister to not extend price controls to additional medical devices. When India refused to heed to the request, amongst other things, the National Trade Estimate Report on Foreign Trade Barriers reported the measure of price capping to be without a sense of differentiation between newer and older products (here, p. 235), India’s eligibility for US’ Generalized System of Preferences (GSP)

Drug Price Controls in the US: Same, Same but Different? Read More »

[Sponsored] LexisNexis Webinar on ‘Calling for Action: How to Track and Measure Sustainable Innovation and Investments’ [October 19]

/ By / Opportunities, Patent, Sponsored

We’re pleased to bring you this announcement by LexisNexis on their launch of a new Sustainable Innovation Measurement framework to enable organizations globally to objectively track and report on innovation’s contribution to the United Nations Sustainable Development Goals. They are also holding a webinar on ‘Calling for Action: How to Track and Measure Sustainable Innovation and Investments’ on October 19, 2021, the details of which can be viewed below. Introducing a New Objective Way to Track and Measure Sustainable Innovation

[Sponsored] LexisNexis Webinar on ‘Calling for Action: How to Track and Measure Sustainable Innovation and Investments’ [October 19] Read More »

Strategic Legal Algorithms Against Public Participation: YouTube Disables Newslaundry’s Account Following Copyright Claims from Aaj Tak

/ By / Copyright

In a new low for Indian media, Aaj Tak (owned by the media conglomerate Living Media) has allegedly taken to using copyright claims to prevent criticism of its reportage by media watchdog Newslaundry. On October 8, Newslaundry staff revealed that its YouTube operations had been stalled pending an enquiry into 53 separate copyright notices received by YouTube from Aaj Tak. The videos flagged (according to Newslaundry, not independently verified by us) pertained to Newslaundry’s commentary and criticism of Aaj Tak’s

Strategic Legal Algorithms Against Public Participation: YouTube Disables Newslaundry’s Account Following Copyright Claims from Aaj Tak Read More »

International Webinar on ‘Vaccines and Immunization: Ethical and Legal Implications’ [October 18]

/ By / COVID-19, Opportunities

We’re pleased to inform you that the Centre for Health Law and Policy (CHLP), the Centre for Human Rights (CHR) and the Centre for Intellectual Property Rights (CIPR) under the aegis of the National University of Advanced Legal Studies (NUALS), in collaboration with the Prof. N R Madhava Menon Interdisciplinary Centre for Research Ethics and Protocols (ICREP), CUSAT and the Kerala State Higher Education Council are conducting an international webinar on ‘Vaccines and Immunization: Ethical and Legal Implications’ on October

International Webinar on ‘Vaccines and Immunization: Ethical and Legal Implications’ [October 18] Read More »

SpicyIP Weekly Review (September 27 – October 3)

/ By / Copyright, Drug Regulation, Geographical Indication, Patent, Trademark

Zolgensma and the Inadequacies of the Compulsory Licensing Regime In a guest post, Akhil wrote about Zolgensma, Novartis’ gene therapy medication prescribed for treatment of Spinal Muscular Atrophy (‘SMA’). Akhil discusses the compulsory licensing provisions in the TRIPS Agreement, as well as the objectives and principles relating to safeguarding public interest in Articles 7 and 8 and how they find reflection in India’s Patent Act. Breaking down the 3 tests of reasonably meeting the requirements of public, reasonable affordability and

SpicyIP Weekly Review (September 27 – October 3) Read More »

Webinar on ‘Traditional Knowledge as Intellectual Property: Opportunities and Challenges at the International Level’ [October 13]

/ By / Opportunities, Traditional Knowledge

We are pleased to inform you that the Microsoft IPR Chair and the DPIIT IPR Chair at Gujarat National Law University (GNLU), Gandhinagar are jointly organising a webinar on ‘Traditional Knowledge as Intellectual Property: Opportunities and Challenges at the International Level’ on 13th October, 2021. Webinar on ‘Traditional Knowledge as Intellectual Property: Opportunities and Challenges at the International Level’ We are elated to announce that the Microsoft- IPR Chair-GNLU and DPIIT IPR Chair-GNLU are jointly organising a webinar on “Traditional

Webinar on ‘Traditional Knowledge as Intellectual Property: Opportunities and Challenges at the International Level’ [October 13] Read More »

Webinar on Digital Sequence Information (DSI): Implications on Access & Benefit Sharing [October 4-7]

/ By / Biological Diversity, Opportunities

We’re pleased to inform you that the DPIIT IPR Chair of Inter University Centre for Intellectual Property Rights Studies at the Cochin University of Science and Technology (CUSAT) is organizing a four day webinar on “Digital Sequence Information(DSI)- Implications on Access and Benefit Sharing” from October 4-7 2021. For further details, please read the announcement below. Webinar on Digital Sequence Information (DSI): Implications on Access & Benefit Sharing The four-day webinar aims to sensitise the legal fraternity about the challenges posed

Webinar on Digital Sequence Information (DSI): Implications on Access & Benefit Sharing [October 4-7] Read More »

Zolgensma and the Inadequacies of the Compulsory Licensing Regime

/ By / Patent

We’re pleased to bring to you a guest post by Akhil Satheesh. Akhil is a final year B.A.L.L.B.(Hons.) student from NUALS, Kochi. Zolgensma and the Inadequacies of the Compulsory Licensing Regime Akhil Satheesh What is the price of an ordinary human life? Although the answers may be imprecise and deeply rooted in philosophical quandaries, for those suffering from a rare genetic degenerative disorder, Novartis answers the question, valuing life at 2.1 million dollars (Rs. 16 crore). This was the price

Zolgensma and the Inadequacies of the Compulsory Licensing Regime Read More »

JDCIL-ESYA Article Writing Competition [Submit by September 30]

/ By / Opportunities

We’re pleased to inform you that the Jindal Digest for Competition and Innovation Laws, in collaboration with Esya Centre, is organizing an article writing Competition, with an aim to encourage academic research on the intersections of competition, IP and technology laws. For details, please read the announcement below. JDCIL-ESYA Article Writing Competition About: The Jindal Digest for Competition and Innovation Laws is an interdisciplinary, student-edited, legal review blog, that aims to trace developments in the fields of Competition Law, Technology

JDCIL-ESYA Article Writing Competition [Submit by September 30] Read More »

Scroll to Top